News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ok.You got it.I wish 4 U the best. I'm playing with this game 17 years .But you're right.It's not important at all.Have a great weekend.
If AVMD will again show gains, the SP should react accordingly!
P.S.: I bought my first shares in 1980. My father was a bank director of Credit Suisse in Zurich (Switzerland). So I heard a lot about stock markets since the sixties. Don't think, you're longer invested in stock markets then me and don't know how important that would be!
GLTY, Claude Alain
LOL.Dude..You got to learn little from long time investors.
Today AVMD - 60% PPS at 0.01...Now yo can buy if you trust so much that AVMD is not BS stock.Lets wait for price below 0.01 so I can load a little more in the case that you are right.So far is 1-0 for me ...However it's not to funny at all.GL
niter... Did somebody buy those "BS stocks" for you without consulting you? Or did you buy those "BS stocks" yourself? Did you do any DD or just buy randomly?
My point is, you should know who is to blame!
GLTY, Claude Alain
P.S.: I don't think AVMD is one of those "BS stocks", but a lot of patience is needed.
.jpg)
If you say so. You're the king of the stock markets. It's you who made millions and now can retire and don't have to post messages on message boards anymore. Congratulations and Bye-bye!
GLTY, Claude Alain
|
Followers
|
8
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1241
|
|
Created
|
10/23/09
|
Type
|
Free
|
| Moderators | |||
http://www.amiaustralia.com.au/
http://www.avmd.com.au
Mission Statement
Advanced Medical Institute Inc. (collectively with its subsidiaries, “AVMD”) focuses on delivering safer, faster acting and lower dosage treatments to people suffering from impotence and premature ejaculation. Unlike many of our competitors, we treat the whole patient, individually and over the long term. AVMD’s strategy is to provide new methods of treatment and delivery systems that provide a practical non-invasive method of drug delivery to the body and by using existing drug products with known safety and efficacy. We market directly to the public. All medications are provided under individual prescriptions and our treatments are only available through our dedicated clinics under the supervision of trained medical personnel. At present our treatments are only available in Australia, New Zealand, China and the United Kingdom.
Company
AVMD, headquartered in Sydney, Australia, is a publicly held Nevada corporation that currently trades on the over-the-counter (bulletin board) market under the symbol AVMD.OB. AVMD operates primarily through its wholly-owned Australian subsidiary, AMI Australia. Please click here to access our current corporate structure chart. AVMD currently has approximately 53.5 million issued shares.Please click here to obtain further information on AVMD’s issued capital and a copy of AVMD’s financial reports.
Future Goals
One of AVMD’s goals is to extend the reach of our innovative treatment programs beyond Australia, New Zealand, China and the United Kingdom. We are exploring growth opportunities in Asia, Europe and the United States and on September 15, 2008, we announced expansion of our operations to the United Kingdom where we opened up our treatment centers, contracts with independent doctors and pharmacies and began airing infomercials throughout the country.
Based on publicly available Australian and Worldwide market information, the sexual dysfunction market share we have achieved in Australia and our analysis of the regulatory and market opportunities available in the United States and elsewhere, we are extremely excited by our prospects and our opportunities for growth in the coming years.
Latest 10Q Ending Sept 30, 2009
| September 30, 2009 | June 30, 2009 | |||||||
| ASSETS | ||||||||
| CURRENT ASSETS | ||||||||
| Cash & cash equivalents | $ | 344,270 | $ | 295,245 | ||||
| Receivables, net | 27,632,227 | 24,021,361 | ||||||
| Receivables due from related parties | 380,677 | 428,525 | ||||||
| Inventory | 897,671 | 911,405 | ||||||
| Other assets | 813,678 | 1,014,424 | ||||||
| TOTAL CURRENT ASSETS | 30,068,523 | 26,670,960 | ||||||
| NON-CURRENT ASSETS | ||||||||
| Security deposits | 191,384 | 181,584 | ||||||
| Property and equipment, net | 1,717,528 | 1,630,979 | ||||||
| Assets related to discontinued operations | 301,542 | 289,977 | ||||||
| Deferred tax assets | 264,479 | 678,270 | ||||||
| Intangible assets, net | 19,538,754 | 18,327,078 | ||||||
| TOTAL NON-CURRENT ASSETS | 22,013,687 | 21,107,888 | ||||||
| TOTAL ASSETS | $ | 52,082,210 | $ | 47,778,848 | ||||
| Three Month Periods Ended | ||||||||
| September 30, 2009 | September 30, 2008 | |||||||
| NET REVENUE | $ | 14,507,711 | $ | 15,944,448 | ||||
| COST OF REVENUE | (3,291,231 | ) | (3,591,200 | ) | ||||
| GROSS PROFIT | 11,216,480 | 12,353,248 | ||||||
| SELLING, GENERAL AND ADMINISTRATIVE EXPENSES | (9,774,975 | ) | (11,753,265 | ) | ||||
| OPERATING INCOME | 1,441,505 | 599,983 | ||||||
| OTHER INCOME AND (EXPENSE) | ||||||||
| Bank interest | 1,736 | 34,610 | ||||||
| Other income | - | 20,646 | ||||||
| Interest expense | (154,022 | ) | (71,745 | ) | ||||
| TOTAL OTHER INCOME (EXPENSE) | (152,286 | ) | (16,489 | ) | ||||
| INCOME FROM CONTINUED OPERATIONS | 1,289,219 | 583,494 | ||||||
| DISCONTINUED OPERATIONS | ||||||||
| Loss from discontinued operations | (23,334 | ) | (95,001 | ) | ||||
| Total loss from discontinued operations | (23,334 | ) | (95,001 | ) | ||||
| INCOME BEFORE INCOME TAXES | 1,265,885 | 488,493 | ||||||
| INCOME TAX EXPENSE | (449,333 | ) | (373,847 | ) | ||||
| NET INCOME | 816,552 | 114,646 | ||||||
| Other Comprehensive item - Foreign currency translation income (loss) | 1,179,276 | (4,854,822 | ) | |||||
| Net Comprehensive Income (Loss) | $ | 1,995,828 | $ | (4,740,176 | ) | |||
| Earnings per common share – continued operations | $ | 0.02 | $ | 0.00 | ||||
| Earnings per common share – discontinued operations | $ | (0.00 | ) | $ | 0.00 | |||
| Earnings per common share – basic & diluted | $ | 0.02 | $ | 0.00 | ||||
| Weighted average number of shares, basic & diluted | 53,507,450 | 53,507,450 | | |||||
Assets
AVMD’s wholly owned subsidiary, AMI Australia operates a centralized call center and twenty medical centers and sales offices throughout Australia, New Zealand, China and the United Kingdom.
AVMD’s core assets includes significant unique proprietary intellectual property developed during our subsidiaries’ business 16 years operating history. Our proprietary intellectual property includes:
Management
|
| Dr. Vaisman is the chief executive officer and a director of AVMD. Dr. Vaisman is a pioneer in the treatment of sexual dysfunction (impotence and premature ejaculation) in Australia. Since 2001, he has served as the Managing Director and Chief Executive Officer of AMI Australia, AVMD’s chief operating subsidiary. He is responsible for the overall management and strategic direction of AMI Australia's business operations. Dr. Vaisman was also the Founder and Director of On Clinic International in Australia. The holder of a Bachelor of Medicine, a Master of Gynaecology and a PhD in Medical Science, he has more than 35 years of experience and expertise in the field of sexual health care and was recently granted an innovation patent relating to the treatment of premature ejaculation by the Australian patent office. |
 | |
|
| Mr. Khan is AVMD’s Chief Operating Officer. Mr. Khan has served as Secretary and a Director of the Company since April 7, 2005. Mr. Khan also served as the chief operating officer of AMI Australia since July 1, 2005. From 2001 to July 1, 2005, Mr. Khan was the General Manager of AMI Australia, AVMD’s chief operating subsidiary. Previously, Khan founded, was the director and was the sole shareholder of Australian Momentum Health Pty Limited, a provider of impotency treatments in Australia and a predecessor of AMI Australia. Before founding Australian Momentum Health, he was Sales Manager and Operations Manager for On Clinic International Pty Limited. Mr. Khan holds a Masters degree in Commerce and Accounting and has been involved in the sexual dysfunction industry for over 10 years. |
|
| |
|
| Mr. Shrestha is the Chief Financial Officer of AVMD. Mr. Shrestha joined AMI Australia, AVMD’s chief operating subsidiary, in 2001 as a financial controller and was named Chief Financial Officer of AVMD on April 7, 2005. Prior to joining AMI Australia, he was a financial officer with Australian Momentum Health Pty Limited (a predecessor company of AMI Australia), a position he held from 1999 until 2001. He began his career as an operations and information technology manager with Kalinchowk Trading Company Ltd. Mr. Shrestha holds a Master’s degree in E-Commerce, a Graduate Diploma of Information Systems and E-Commerce and a Bachelor of Business Accounting. Mr. Shrestha is the co-developer of AVMD’s in-house proprietary enterprise software which is designed to oversee and manage AVMD’s business operations and which incorporates a customer management system that tracks customers from first contact to treatment program completion. |
|
| |
SHARE STRUCTURE
As of November 23, 2009
Authorized Shares: 100,000,000
Outstanding Shares: 53,507,450
Float: 30,240,450
| Name and Address of Beneficial Owner | Shares Beneficially Owned (1) | Percent of Class | ||||||
| Jacov (Jack) Vaisman Unit 131 18-34 Waverley Street Bondi Junction NSW 2022 Australia | 10,250,000 | 19.16 | % | |||||
| Forhad (Tony) Khan Suite 4, Level 1 26/3 Wolesly Grove Zetland NSW 2017 Australia | 250,000 | * | ||||||
| Dilip Shrestha 18/30 Mary Street Lidcambe NSW 2141 Australia | 0 | * | ||||||
| Anatoly Fanshil 22/2 Ocean Street Bondi Junction NSW 2026 Australia | 517,000 | * | ||||||
| Spiro Baramilis 12 Merton Street Kogarah Bay NSW 2217 Australia | 0 | * | ||||||
| Geissler Holdings Limited 1 Raffles Place #21-01 OUB Centre Singapore 048616 | 8,850,000 | (2) | 16.54 | % | ||||
| RRD Investments Pty Limited 65 Prospect Road Summer Hills, NSW 2130 Australia | 3,400,000 | (3) | 6.35 | % | ||||
| All Directors and Officers (5 people) | 11,017,000 | 20.59 | % | |||||
AI
